Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Ensysce Biosciences (ENSC US)
Watchlist
22
Analysis
Health Care
•
United States
Ensysce Biosciences, Inc. operates as a clinical stage biotech company. The Company focuses on stemming the prescription drug abuse epidemic. Ensysce Biosciences serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Ensysce Biosciences
•
14 Nov 2024 01:00
•
Issuer-paid
ENSC: Results Show Solid Cash and Good Prospects
Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...
Zacks Small Cap Research
Follow
223 Views
Share
bullish
•
Ensysce Biosciences
•
31 Aug 2024 01:00
•
Issuer-paid
ENSC: Substantial Federal Funds Granted
Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...
Zacks Small Cap Research
Follow
415 Views
Share
bullish
•
Ensysce Biosciences
•
27 Aug 2024 23:00
•
Issuer-paid
ENSC: Substantial Federal Funds Granted
Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...
Zacks Small Cap Research
Follow
307 Views
Share
bullish
•
Ensysce Biosciences
•
16 Aug 2024 01:00
•
Issuer-paid
ENSC: 2Q Release Sets Stage for Important Trials
Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...
Zacks Small Cap Research
Follow
321 Views
Share
bullish
•
Ensysce Biosciences
•
14 May 2024 00:00
•
Issuer-paid
ENSC: 1Q Release Highlights Financial and Scientific Progress
Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...
Zacks Small Cap Research
Follow
312 Views
Share
First
Previous
1
2
3
4
5
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x